Kent Holtorf, MD – Mold and CIRS – 2022 Conference (LDN; low dose naltrexone)
Kent Holtorf, MD – Mold and CIRS – 2022 Conference (LDN; low dose naltrexone)
Kristen Cardamone, DO, FABPMR – LDN in Pain – 2022 Conference (LDN; low dose naltrexone)
Kristen Cardamone, DO, FABPMR – LDN in Pain – 2022 Conference (LDN; low dose naltrexone)
Phil Boyle, MRCGP, MICGP – PMS and PMDD – LDN Side Effects – 2022 Conference (LDN; low dose naltrexone)
Phil Boyle, MRCGP, MICGP – PMS and PMDD – LDN Side Effects – 2022 Conference (LDN; low dose naltrexone)
Harpal Bains, MBBS, DFSRH, PGC Aest Med (Dist) – LDN Side Effects – 2022 Conference (LDN; low dose naltrexone)
Harpal Bains, MBBS, DFSRH, PGC Aest Med (Dist) – LDN Side Effects – 2022 Conference (LDN; low dose naltrexone)
Harpal Bains, MBBS, DFSRH, PGC Aest Med (Dist) – Behcet’s Disease – 2022 Conference (LDN; low dose naltrexone
Harpal Bains, MBBS, DFSRH, PGC Aest Med (Dist) – Behcet’s Disease – 2022 Conference (LDN; low dose naltrexone)
Nellmarie Bodenstein, GP – Clinical use of LDN in South Africa – 2022 Conference (LDN, low dose naltrexone)
Nellmarie Bodenstein, GP – Clinical use of LDN in South Africa – 2022 Conference (LDN, low dose naltrexone)
Elizabeth Livengood, NMD – LDN and Thyroid – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Elizabeth Livengood, NMD – LDN and Thyroid – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Elizabeth Livengood, NMD – Major Depressive Disorder – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Elizabeth Livengood, NMD – Major Depressive Disorder – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Edyta Biernat-Kałuża, MD, PhD – Pain – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Edyta Biernat-Kałuża, MD, PhD – Pain – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Yusuf Saleeby, MD – IBD – 2020 Conference; Bahamas (LDN, low dose naltrexone)
Yusuf Saleeby, MD – IBD – 2020 Conference; Bahamas (LDN, low dose naltrexone)